1. Real-world data from the use of ranolazine in patients with stable angina pectoris: the RANGER study. (3rd October 2022) Authors: Stafylas, P; Olympios, C; Dermitzakis, A; Efthimiadis, I; Gardikiotis, A; Kakouros, S; Lampropoulos, S; Barbetseas, J; Sourgounis, A Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗